BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections have changed since certain non-multiresistant MRSA lineages have emerged in hospitals. In this study, 99 MRSA isolates, 77 from a public and 22 from a private hospital, were characterized. METHODS: Isolates were tested for antimicrobial susceptibility, whereas staphylococcal chromosomal cassette mec (SCCmec) typing and Panton-Valentine leukocidin genes were assessed by polymerase chain reaction. Pulsed-field gel electrophoresis and multilocus sequence typing analyses were carried out to determine the MRSA lineages. RESULTS: High rates of resistance were found to erythromycin (96%), ciprofloxacin (93%), and clindamycin (90%). The SCCmec types found were as follows: type II (14.2%), III (62.6%), and IV (23.2%). Approximately 85% of type III isolates was related to the Brazilian epidemic clone in both hospitals. For type IV isolates, 94.4% were related to both USA400/ sequence type (ST) 1 and USA800/ST5 lineages in the public hospital, whereas the USA400/ST1, USA800/ST5, USA1100/ST30, and EMRSA (Epidemic MRSA)-15/ST22 lineages were detected in the private hospital. Among the SCCmec II isolates, approximately 85% were related to the USA100/ST5 lineage. Three MRSA isolates were positive to Panton-Valentine leukocidin genes. CONCLUSION: The study showed that there was an emergence of USA400/ST1, USA800/ST5 SCCmec IV, and USA100/ST5 SCCmec II MRSA lineages in both hospitals. There was a dissemination of them in the public hospital and a polyclonal presence of the MRSA isolates in the private hospital. The spread of these lineages can be facilitated by the characteristics of the health institution.
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections have changed since certain non-multiresistant MRSA lineages have emerged in hospitals. In this study, 99 MRSA isolates, 77 from a public and 22 from a private hospital, were characterized. METHODS: Isolates were tested for antimicrobial susceptibility, whereas staphylococcal chromosomal cassette mec (SCCmec) typing and Panton-Valentine leukocidin genes were assessed by polymerase chain reaction. Pulsed-field gel electrophoresis and multilocus sequence typing analyses were carried out to determine the MRSA lineages. RESULTS: High rates of resistance were found to erythromycin (96%), ciprofloxacin (93%), and clindamycin (90%). The SCCmec types found were as follows: type II (14.2%), III (62.6%), and IV (23.2%). Approximately 85% of type III isolates was related to the Brazilian epidemic clone in both hospitals. For type IV isolates, 94.4% were related to both USA400/ sequence type (ST) 1 and USA800/ST5 lineages in the public hospital, whereas the USA400/ST1, USA800/ST5, USA1100/ST30, and EMRSA (Epidemic MRSA)-15/ST22 lineages were detected in the private hospital. Among the SCCmec II isolates, approximately 85% were related to the USA100/ST5 lineage. Three MRSA isolates were positive to Panton-Valentine leukocidin genes. CONCLUSION: The study showed that there was an emergence of USA400/ST1, USA800/ST5 SCCmec IV, and USA100/ST5 SCCmec II MRSA lineages in both hospitals. There was a dissemination of them in the public hospital and a polyclonal presence of the MRSA isolates in the private hospital. The spread of these lineages can be facilitated by the characteristics of the health institution.
Authors: Jéssica Bomfim de Almeida; Suzi Pacheco de Carvalho; Lucas S C da Silva; Yasmin M F S Andrade; Raiane Cardoso Chamon; Kátia Regina Netto Dos Santos; Lucas M Marques Journal: Braz J Microbiol Date: 2020-08-21 Impact factor: 2.476
Authors: P V Damasco; F S Cavalcante; R C Chamon; D C Ferreira; S S Rioja; M V Potsch; M P Pastura; V D Marques; M B Castier; E A Marques; K R N Santos Journal: Infection Date: 2013-03-02 Impact factor: 3.553
Authors: F S Cavalcante; E D Abad; Y C Lyra; S B Saintive; M Ribeiro; D C Ferreira; K R N dos Santos Journal: Braz J Med Biol Res Date: 2015-05-08 Impact factor: 2.590
Authors: Fernanda S Cavalcante; Dennis de C Ferreira; Raiane C Chamon; Thaina M da Costa; Fernanda Maia; Elaine M Barros; Tatiana Silva Dantas; Kátia R N Dos Santos Journal: BMC Res Notes Date: 2014-10-25
Authors: Diana Panesso; Paul J Planet; Lorena Diaz; Jean-Emmanuel Hugonnet; Truc T Tran; Apurva Narechania; Jose M Munita; Sandra Rincon; Lina P Carvajal; Jinnethe Reyes; Alejandra Londoño; Hannah Smith; Robert Sebra; Gintaras Deikus; George M Weinstock; Barbara E Murray; Flavia Rossi; Michel Arthur; Cesar A Arias Journal: Emerg Infect Dis Date: 2015-10 Impact factor: 6.883
Authors: Eneida Dias Vianna Braga; Fábio Aguiar-Alves; Maria de Fátima Nogueira de Freitas; Monique Oliveira de e Silva; Thami Valadares Correa; Robert E Snyder; Verônica Afonso de Araújo; Mariel Asbury Marlow; Lee W Riley; Sérgio Setúbal; Licínio Esmeraldo Silva; Claudete Aparecida Araújo Cardoso Journal: BMC Infect Dis Date: 2014-10-06 Impact factor: 3.090
Authors: Anna C Shore; Alexandros Lazaris; Peter M Kinnevey; Orla M Brennan; Gráinne I Brennan; Brian O'Connell; Andrea T Feßler; Stefan Schwarz; David C Coleman Journal: Antimicrob Agents Chemother Date: 2016-04-22 Impact factor: 5.191